Chemotherapy for renal cell carcinoma.
Renal cell carcinoma is highly resistant to systemic chemotherapy, and no agent should be considered standard in the treatment of metastatic disease. At this time, it is appropriate for patients with advanced local or metastatic renal cell carcinoma to be offered new therapeutic investigational experimental options, since clearly there are limited therapies presently available. The experience with chemotherapy is reviewed.
Amato
R J
RJ
Department of Genitourinary Medical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D018432:Drug Resistance, Multiple; D004359:Drug Therapy, Combination; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D009362:Neoplasm Metastasis
D000970:Antineoplastic Agents